Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Get the latest updates from Roche Media News directly as they happen.
Follow now 323 followers
Last updated about 3 hours ago
about 3 hours ago
89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe...
13 days ago
In AVONELLE-X, the largest long-term extension trial in nAMD, disease control and...
14 days ago
Susvimo is under review with the EMA and once approved will be...
19 days ago
Phase III trial informed by comprehensive KARDIA data set generated through three...
24 days ago
The $700 million project is part of Roche’s $50 billion investment in...
about 2 months ago
Susvimo is the only continuous delivery treatment to provide reliable, long-term vision...
about 2 months ago
Trontinemab’s Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust...
about 2 months ago
EMA’s CHMP issued an opinion not to recommend Elevidys™ (delandistrogene moxeparvovec) for...
about 2 months ago
Basel, 24 July 2025 Group sales grew by 7%1 at constant exchange...
about 2 months ago
Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test...
about 2 months ago
Approval based on INAVO120 data showing the Itovebi™ (inavolisib)-based regimen more than...
about 2 months ago
Participation certificates (Partizipationsscheine) with a nominal value of CHF 0.001 each will...